Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of seizure activity that does not involve visible shaking or convulsions (called non-convulsive status epilepticus)
- You received the study medication before arriving at a medical facility (such as at home or on the way to hospital)
- You received an extra dose of the study medication as part of your treatment
Who may not be able to join:
- You have any medical reason why you cannot safely take a medication called midazolam (a sedative commonly used to treat seizures)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Clinigen K.K.
Phone: +81-3-6869-0663
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants Who Experienced At Least One Treatment-Emergent Adverse Event (TEAE); Number of Participants With Serious Adverse Events; Number of Participants With Therapeutic Success
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.